Scavilla Daniel T 4
4 · GLOBUS MEDICAL INC · Filed Nov 8, 2024
Insider Transaction Report
Form 4
Scavilla Daniel T
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2024-11-06$26.27/sh+30,000$788,100→ 30,000 total - Exercise/Conversion
Class A Common Stock
2024-11-06$43.77/sh+30,000$1,313,100→ 60,000 total - Sale
Class A Common Stock
2024-11-06$80.02/sh−60,000$4,801,200→ 0 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-06+30,000→ 0 totalExercise: $26.27Exp: 2027-01-30→ Class A Common Stock (30,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-06+30,000→ 50,000 totalExercise: $43.77Exp: 2028-01-22→ Class A Common Stock (30,000 underlying)
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person.
- [F2]These options were granted on January 30, 2017 and are fully vested.
- [F3]These options were granted on January 22, 2018 and are fully vested.